IL1B and COVID-19: In the present study, we have sought to address this gap, describing the derivation and validation of IL-1β and IL-6 inducible transcriptional modules and testing the hypothesis that these modules can be used in the molecular assessment of the pathophysiology and the response to therapeutic cytokine blockade of inflammatory conditions, including COVID-19.